VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients – News-Medical.net
|
VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients
News-Medical.net Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients … Cutting-edge immunotherapy treatment approved for another deadly cancer |
